Your browser doesn't support javascript.
loading
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.
Slieker, Roderick C; Donnelly, Louise A; Fitipaldi, Hugo; Bouland, Gerard A; Giordano, Giuseppe N; Åkerlund, Mikael; Gerl, Mathias J; Ahlqvist, Emma; Ali, Ashfaq; Dragan, Iulian; Festa, Andreas; Hansen, Michael K; Mansour Aly, Dina; Kim, Min; Kuznetsov, Dmitry; Mehl, Florence; Klose, Christian; Simons, Kai; Pavo, Imre; Pullen, Timothy J; Suvitaival, Tommi; Wretlind, Asger; Rossing, Peter; Lyssenko, Valeriya; Legido-Quigley, Cristina; Groop, Leif; Thorens, Bernard; Franks, Paul W; Ibberson, Mark; Rutter, Guy A; Beulens, Joline W J; 't Hart, Leen M; Pearson, Ewan R.
Affiliation
  • Slieker RC; Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam UMC, Location VUMC, Amsterdam, the Netherlands.
  • Donnelly LA; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Fitipaldi H; Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.
  • Bouland GA; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Giordano GN; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Åkerlund M; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Gerl MJ; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Ahlqvist E; Lipotype GmbH, Dresden, Germany.
  • Ali A; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Dragan I; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Festa A; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Hansen MK; Eli Lilly Regional Operations GmbH, Vienna, Austria.
  • Mansour Aly D; 1st Medical Department, LK Stockerau, Niederösterreich, Austria.
  • Kim M; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, USA.
  • Kuznetsov D; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Mehl F; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Klose C; Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King's College London, London, UK.
  • Simons K; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Pavo I; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Pullen TJ; Lipotype GmbH, Dresden, Germany.
  • Suvitaival T; Lipotype GmbH, Dresden, Germany.
  • Wretlind A; Eli Lilly Regional Operations GmbH, Vienna, Austria.
  • Rossing P; Department of Diabetes, Guy's Campus King's College London, London, UK.
  • Lyssenko V; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Legido-Quigley C; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Groop L; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Thorens B; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Franks PW; Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway.
  • Ibberson M; Genomics, Diabetes and Endocrinology Unit, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden.
  • Rutter GA; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Beulens JWJ; Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King's College London, London, UK.
  • 't Hart LM; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, CRC, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Pearson ER; Finnish Institute of Molecular Medicine, Helsinki University, Helsinki, Finland.
Diabetologia ; 64(9): 1982-1989, 2021 09.
Article de En | MEDLINE | ID: mdl-34110439
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Diabète de type 2 Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Diabetologia Année: 2021 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Diabète de type 2 Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Diabetologia Année: 2021 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Allemagne